| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| xl844 | checkpoint kinase-1 | NA | Clinical trial target | TTD , DGIDB | Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
NA | discontinued in phase 1 | unknown |
| xl844 | serine/threonine-protein kinase chk1 | small molecule | NA | drugbank , DGIDB | Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
NA | investigational | unknown |
| xl844 | serine/threonine-protein kinase chk2 | small molecule | Clinical trial target | TTD , drugbank , DGIDB | Neoplasms[MeSHID:D009369] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Malignant Neoplasms[MeSHID:D009369] |
NA | investigational,discontinued in phase 1 | unknown |
| click here to return to the previous page | ||||||||